Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK097 is a highly potent and selective inhibitor of the second bromodomain (BD2) found in bromodomain and extra-terminal domain (BET) proteins. It exhibits a remarkable 2000-fold selectivity for BD2 over BD1, as indicated by BRD4 data. Additionally, GSK097 demonstrates solubility of over 1 mg/mL in FaSSIF media.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | GSK097 is a highly potent and selective inhibitor of the second bromodomain (BD2) found in bromodomain and extra-terminal domain (BET) proteins. It exhibits a remarkable 2000-fold selectivity for BD2 over BD1, as indicated by BRD4 data. Additionally, GSK097 demonstrates solubility of over 1 mg/mL in FaSSIF media. |
In vitro | GSK097 exhibits potent inhibitory activity, as indicated by pIC50 values of 7.4, 8.0, 7.6, and 7.9, against BRD2 (BD2), BRD3 (BD2), BRD4 (BD2), and BRDT (BD2), respectively[1]. |
Molecular Weight | 339.395 |
Formula | C19H21N3O3 |
CAS No. | 2159137-02-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK097 2159137-02-5 GSK-097 GSK 097 inhibitor inhibit